See Stories from Region:
Filter by Date:
 
  • close  
  • close  
RSS – Vision 
News > Medical > Vision

Featured

April 1, 2015 - 06:10 AM

LENSAR Receives FDA Clearance of Five New Performance Application Upgrades to the LENSAR Laser System

First Laser Cataract Platform to Automate Key Procedure Steps LENSAR to…

Read More
April 1, 2015 - 05:33 AM

Kala Pharmaceuticals Announces Positive Results from Phase 3 Trial of KPI-121 in Cataract Surgery

  - KPI-121 meets all primary endpoints, achieving statistical superiority over…

Read More
April 1, 2015 - 05:32 AM

Kala Pharmaceuticals Announces Positive Results from Phase 2 Trial of KPI-121 in Dry Eye Disease

- KPI-121 meets primary sign endpoint, demonstrating statistical superiority over…

Read More

Latest

April 1, 2015 - 06:10 AM

LENSAR Receives FDA Clearance of Five New Performance Application Upgrades to the LENSAR Laser System

First Laser Cataract Platform to Automate Key Procedure Steps LENSAR to Unveil LENSAR Laser System with Streamline™ at ASCRS…

Read More
April 1, 2015 - 05:33 AM

Kala Pharmaceuticals Announces Positive Results from Phase 3 Trial of KPI-121 in Cataract Surgery

  - KPI-121 meets all primary endpoints, achieving statistical superiority over vehicle for elimination of inflammation and pain…

Read More
April 1, 2015 - 05:32 AM

Kala Pharmaceuticals Announces Positive Results from Phase 2 Trial of KPI-121 in Dry Eye Disease

- KPI-121 meets primary sign endpoint, demonstrating statistical superiority over vehicle in reducing conjunctival hyperemia - …

Read More
March 31, 2015 - 04:07 PM

Acucela Granted New Patent Covering Method of Use for Emixustat Hydrochloride

Read More
March 31, 2015 - 09:00 AM

Avedro Announces Receipt of Complete Response Letter from FDA for Corneal Cross-Linking NDA

Avedro announces receipt of complete response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for their…

Read More
Promoted Stories by dlvr.it
March 31, 2015 - 05:58 AM

Ocata Therapeutics Successfully Completes Dosing in Phase 1/2 RPE Studies

SMD Pivotal Trial and AMD Phase 2 Trial to be Initiated

Read More